Aim Immunotech logo

Aim Immunotech Share Price (NYSE: AIM)

$2.42

-0.12

(-4.72%)

Last updated on

Check the interactive Aim Immunotech Stock chart to analyse performance

Aim Immunotech stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.42
    Today's High:$2.53

    Day's Volatility :4.35%

  • 52 Weeks Low:$0.06
    52 Weeks High:$20.35

    52 Weeks Volatility :99.69%

Aim Immunotech Stock Returns

PeriodAim Immunotech IncIndex (Russel 2000)
3 Months
-76.16%
0.0%
6 Months
1914.99%
0.0%
1 Year
595.4%
0.0%
3 Years
282.37%
-4.7%

Aim Immunotech Inc Key Stats

Check Aim Immunotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.54
Open
$2.53
Today's High
$2.53
Today's Low
$2.42
Market Capitalization
$6.9M
Today's Volume
$57.6K
52 Week High
$20.35
52 Week Low
$0.0633
Revenue TTM
$121.0K
EBITDA
$-16.4M
Earnings Per Share (EPS)
$-24.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3138.91%

Stock Returns calculator for Aim Immunotech Stock including INR - Dollar returns

The Aim Immunotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aim Immunotech investment value today

Current value as on today

₹6,96,713

Returns

₹5,96,713

(+596.71%)

Returns from Aim Immunotech Stock

₹5,91,429 (+591.43%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Aim Immunotech Stock

117%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Aim Immunotech Stock from India on INDmoney has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Aim Immunotech Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Aim Immunotech(by analysts ranked 0 to 5 stars)

Aim Immunotech Share Price Target

What analysts predicted

Upside of 6098.35%

Target:

$150.00

Current:

$2.42

Aim Immunotech share price target is $150.00, a slight Upside of 6098.35% compared to current price of $2.42 as per analysts' prediction.

Aim Immunotech Stock Insights

  • Price Movement

    In the last 3 months, AIM stock has moved up by 2450.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 16.0K → 25.0K (in $), with an average increase of 36.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -5.96M → -2.79M (in $), with an average increase of 46.8% per quarter

Aim Immunotech Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY22
FY22
FY23
FY23
FY24
FY24
FY24Y/Y Change
Revenue
$170.0K
↓ 15.84%
Net Income
$-17.3M
↓ 40.2%
Net Profit Margin
-10.2K%
↑ 4149.38%

Aim Immunotech Technicals Summary

Sell

Neutral

Buy

Aim Immunotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aim Immunotech Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aim Immunotech Inc logo
-17.12%
1914.99%
595.4%
282.37%
9.01%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Aim Immunotech Inc

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Organization
Aim Immunotech
Employees
21
CEO
Mr. Thomas K. Equels Esq., J.D., M.S.
Industry
Health Technology

Key Management of Aim Immunotech Inc

NameTitle
Mr. Thomas K. Equels Esq., J.D., M.S.
Executive Vice Chairman, CEO & President
Mr. Robert Dickey IV, M.B.A.
Chief Financial Officer
Mr. Peter W. Rodino III, Esq., J.D.
COO, Executive Director of Governmental Relations, General Counsel & Secretary
Ann Marie E. Coverly
Director of Administration & Human Resources and Deputy Investor Relations Coordinator

Important FAQs about investing in AIM Stock from India :

What is Aim Immunotech share price today?

Aim Immunotech share price today is $2.42 as on at the close of the market. Aim Immunotech share today touched a day high of $2.53 and a low of $2.42.

What is the 52 week high and 52 week low for Aim Immunotech share?

Aim Immunotech share touched a 52 week high of $20.35 and a 52 week low of $0.06. Aim Immunotech stock price today i.e. is closed at $2.42, lower by 88.11% versus the 52 week high.

How to invest in Aim Immunotech Stock (AIM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aim Immunotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aim Immunotech Shares that will get you 0.6198 shares as per Aim Immunotech share price of $2.42 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aim Immunotech Stock (AIM) from India?

Indian investors can start investing in Aim Immunotech (AIM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aim Immunotech stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Aim Immunotech share’s latest price of $2.42 as on August 30, 2025 at 1:29 am IST, you will get 4.1322 shares of Aim Immunotech. Learn more about fractional shares .

What are the returns that Aim Immunotech has given to Indian investors in the last 5 years?

Aim Immunotech stock has given 9.01% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?